Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults

BACKGROUND: Adjuvanted herpes zoster (HZ) subunit (HZ/su) vaccine is recommended for healthy adults aged ≥50 years, yet vaccine efficacy is expected to wane over time. Age-sex specific cost-effectiveness analyses of HZ/su vaccine are warranted to inform decision-making on vaccine policy. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Joyce H. S., Ming, Wai-kit, Tsang, Owen Tak-yin, Chan, Paul Kay-sheung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319773/
https://www.ncbi.nlm.nih.gov/pubmed/30608953
http://dx.doi.org/10.1371/journal.pone.0210005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319773/
https://www.ncbi.nlm.nih.gov/pubmed/30608953
http://dx.doi.org/10.1371/journal.pone.0210005

Ejemplares similares